It’s Never Too Soon: How and When to Engage Medical Affairs
Engagement with Medical Affairs is critical at every juncture in the drug development process, with Medical Affairs acting as a key liaison between internal stakeholders, a new generation of physicians, and patient advocates...
Read MoreTop Stories
It’s Never Too Soon: How and When to
Engagement with Medical Affairs is critical at every...
Celebrating Health Literacy Month 2024:
October is Health Literacy Month, a reminder of the...
Celebrating World Patient Safety Day 2024:
On World Patient Safety Day 2024, we focus on the critical...
Filter
Clinical Evidence: How Much Is Enough?
Ensuring the safety and functionality of your medical device is vital. But how much clinical...
Medical Information in the Digital Age – Quick and Efficient Meets Responsive and Responsible
Medical Information (MI teams across the pharmaceutical industry respond to product-related medical queries from HCPs...
From Transactional to Transformational: Bringing Patient Centricity to the Next Level
The pharma industry’s focus is shifting from the transactional approach to a transformational approach by...
Digital Scientific Content: Stakeholder Perspectives
What do the different relevant stakeholder groups truly expect from pharma-generated scientific content?...
How Can Preprints Drive Trust in Science?
By tagging preprints with various indicators, badges may represent quality, rigor, and scope. In doing...
Scientific Communication Strategies for Digital Transformation
Read how digital transformation strategies can help to rethink workflows for future readiness and scale-up...
- 1
- 2